03Sep
02Sep
10 PORTFOLIO COMPANIES TO WATCH IN 2022
10 portfolio companies to watch in 2022 selected by Ziad Moukheiber President Boston Harbor Angels. The list is in alphabetical order / Akston Bioscienceshttps://www.akstonbio.com/ Archer Roosehttps://archerroose.com/ Astrocyte Pharmaceuticalshttps://www.astrocytepharma.com/ Cytoagentshttps://www.cytoagents.com/ Futurefuel.iohttps://futurefuel.io/ Revbiohttps://revbio.com/ S'Morehttps://www.smoredate.com/ Wasabi Technologieshttps://wasabi.com/ Winter Innovationshttps://www.winter-innovations.com/ Xeno Bioscienceshttps://www.xenobiosciences.com/
02Sep
Xylyx Bio partners with Inventia Life Science to develop tissue-specific, digitally-printed bioinks for drug discovery
Xylyx Bio, a New York-based leader in advanced biomaterials, and Inventia Life Science, a Sydney-based biotechnology company, today announced their strategic partnership following promising results developing more realistic, scalable, and reproducible 3D cell cultures for drug discovery and biomedical research. Read more >>
01Sep
More accessible Covid-19 vaccines and community engagement key for rural areas
...Fortunately, many of these challenges may be alleviated when second-generation Covid vaccines come on the market. One candidate currently in Phase II trials, Akston Biosciences' AKS-452, is shelf-stable for six months at room temperature and can even withstand temperatures up to 37°C for one month. Crucially, this allows the jab to be transported and stored for months without refrigeration. Read more >>
30Aug
The Best Canned Wines To Pack For Your Next Outdoor Adventure
...While most wine labels select grapes from one particular vineyard or region, Archer Roose sources fruit from countries around the globe, including France, Argentina, Chile, and Greece. Choose from Malbec, Sauvignon Blanc, Rosé, Bubbly, or Rodi Rosé — a skin-macerated orange wine (which is rare to find in cans). Read more >>
21Aug
Second Wave of COVID-19 Vaccines Could Resolve Vaccine Inequity
There’s one significant ray of hope for those frustrated by vaccine inequity: second-generation coronavirus vaccines are currently showing promise in clinical trials, many of which may prove highly effective as well as cheaper and easier to distribute around the world. The AKS-452 candidate produced by Massachusetts-based Akston Biosciences, for example, recently entered Phase II trials at the University Medical Center Groningen (UMCG), one of the largest hospitals in the Netherlands. Read more >>
20Aug
From Defense To Offense: Pixability’s Duffy Flips CTV Suitability On Its Head
Matt Duffy of Pixability, a vendor of brand safety tooling for YouTube and other platforms, describes how the category is evolving. Duffy points to a study from Global Alliance for Responsible Media and data from Comscore showing how comfortable advertisers have become with those channels. “It showed (that) YouTube is now over 99% brand-safe for advertisers,” he says. “According to Comscore, over 40% of CTV watch time is YouTube.” And Pixability just commissioned its own survey of ad buyer attitudes...
18Aug
9 Rhode Island companies make this year’s Inc. 5000 list
Nine Rhode Island-based companies have made this year's Inc. 5000 list, the financial magazine's annual ranking of the fastest-growing privately held companies in the country. Topping the 2021 list among Ocean State companies was Luna Pharmaceuticals, which clocked in at No. 1,852 overall with 245% revenue growth. In fact, Luna Pharmaceuticals is the official name of the company behind Premama Wellness, a Providence-based startup that sells supplements for maternity wellness. Premama last May attracted its first institutional investor since launching...
18Aug
ZetrOZ Systems is Helping Americans Get Back to Work
As America gets back to work, businesses are placing a higher premium on the health and wellbeing of their employees. ZetrOZ Systems, developers of the Sustained Acoustic Medicine (sam®) wearable pain relief ultrasound device, is helping employers minimize the impact and likelihood of workplace injuries. Read more >>
17Aug